Literature DB >> 12388282

Acute effects of 17beta -estradiol on femoral veins from adult gonadally intact and ovariectomized female pigs.

M P Bracamonte1, M Jayachandran, K S Rud, V M Miller.   

Abstract

Our experiments were designed to determine the acute effects of 17beta-estradiol on femoral veins from intact and ovariectomized female pigs. Rings of femoral veins with or without endothelium were suspended in organ chambers for measurement of isometric force. Concentration-response curves to 17beta-estradiol (10(-9) to 10(-5) M) were obtained in veins contracted with prostaglandin F(2alpha) in the absence and presence of inhibitors of either estrogen receptors (ICI-182780; 10(-5) M), nitric oxide synthase [N(G)-monomethyl-l-arginine (l-NMMA); 10(-4) M], soluble guanylate cyclase (1-H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one; 10(-5) M), or potassium channels (tetraethylammonium; 10(-2) M). Estrogen receptors were identified with the use of Western blotting and immunostaining in veins of both groups. 17beta-Estradiol caused acute endothelium-dependent relaxations in both groups. Relaxations to 17beta-estradiol were inhibited by l-NMMA and 1-H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one but not ICI-182780. Tetraethylammonium inhibited relaxations only in veins with endothelium from intact females. Results indicate that 17beta-estradiol causes acute endothelium-dependent relaxations in femoral veins. The relative contribution of nitric oxide and K(+) channels as mechanisms involved in relaxations to 17beta-estradiol in femoral veins is modulated by ovarian status.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12388282     DOI: 10.1152/ajpheart.00184.2002

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  8 in total

1.  Hormone phase influences sympathetic responses to high levels of lower body negative pressure in young healthy women.

Authors:  Charlotte W Usselman; Chantelle A Nielson; Torri A Luchyshyn; Tamara I Gimon; Nicole S Coverdale; Stan H M Van Uum; J Kevin Shoemaker
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-10-12       Impact factor: 3.619

Review 2.  The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function.

Authors:  Matthias R Meyer; Eric R Prossnitz; Matthias Barton
Journal:  Vascul Pharmacol       Date:  2011-07-05       Impact factor: 5.773

3.  17Beta-estradiol elevates cGMP and, via plasma membrane recruitment of protein kinase GIalpha, stimulates Ca2+ efflux from rat hepatocytes.

Authors:  Rebecca C Stratton; Paul E Squires; Anne K Green
Journal:  J Biol Chem       Date:  2010-06-21       Impact factor: 5.157

4.  Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI 182,780.

Authors:  Matthias R Meyer; Oliver Baretella; Eric R Prossnitz; Matthias Barton
Journal:  Pharmacology       Date:  2010-07-17       Impact factor: 2.547

5.  GPER/GPR30 and Regulation of Vascular Tone and Blood Pressure.

Authors:  Matthias R Meyer; Eric R Prossnitz; Matthias Barton
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2011

Review 6.  Vascular actions of estrogens: functional implications.

Authors:  Virginia M Miller; Sue P Duckles
Journal:  Pharmacol Rev       Date:  2008-06-25       Impact factor: 25.468

7.  Activation of bradykinin-sensitive pericardial afferents increases systemic venous tone in conscious rats.

Authors:  Douglas S Martin; Erin Vogel; Jessica Freeling; Casey Reihe
Journal:  Auton Neurosci       Date:  2019-12-26       Impact factor: 3.145

8.  Increase and Redistribution of Sex Hormone Receptors in Premenopausal Women Are Associated with Varicose Vein Remodelling.

Authors:  Natalio García-Honduvilla; Ángel Asúnsolo; Miguel A Ortega; Felipe Sainz; Javier Leal; Pedro Lopez-Hervas; Gemma Pascual; Julia Buján
Journal:  Oxid Med Cell Longev       Date:  2018-09-03       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.